Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ATEC | Common Stock | Options Exercise | $1.4M | +400K | +5.04% | $3.50 | 8.34M | Jun 16, 2021 | Direct | F1, F2 |
transaction | ATEC | Common Stock | Tax liability | -$1.4M | -93.7K | -1.12% | $14.93 | 8.24M | Jun 16, 2021 | Direct | F1, F2, F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ATEC | Warrants to Purchase Common Stock | Options Exercise | $0 | +400K | +6.73% | $0.00 | 6.35M | Jun 16, 2021 | Common Stock | 400K | $3.50 | Direct | F1, F2 |
Id | Content |
---|---|
F1 | Each of Jason Hochberg and Evan Bakst serve on the board of directors of the issuer as a representative of the reporting persons. As a result, each reporting person herein may be deemed a director by deputization for the purposes of Section 16 of the Exchange Act. |
F2 | Paul Segal directly (through his position as manager of L-5 Healthcare Partners, LLC ("L-5")) may be deemed to control L-5 and to have shared voting and investment power with respect to the shares beneficially owned by L-5. As such, Mr. Segal may be deemed to have shared beneficial ownership of the shares beneficially owned by L-5. Mr. Segal, however, disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein. |
F3 | Represents a "cashless exercise" of outstanding warrants. The reporting person received 306,253 shares of Common Stock on cashless exercise of warrants to purchase 400,000 shares of Common Stock. The Company withheld 93,747 shares of Common Stock underlying the warrants for payment of the exercise price, using the VWAP on June 15, 2021 of $14.93, pursuant to the terms of the warrant. |